title: 2005 Medicare payments for chemotherapy will exceed costs.
authors.forename: Sarah L
authors.initials: SL
authors.lastname: Zielinski
mesh_terms: D000932:Antiemetics / Q000008:administration & dosage / Q000191:economics*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000191:economics*; D004164:Diphosphonates / Q000008:administration & dosage / Q000191:economics; D016527:Drug Costs / Q000706:statistics & numerical data*; D005252:Fees, Pharmaceutical / Q000706:statistics & numerical data*; D017829:Granisetron / Q000008:administration & dosage / Q000191:economics; D006801:Humans; D006278:Medicare; D017294:Ondansetron / Q000008:administration & dosage / Q000191:economics; D000077268:Pamidronate; D014481:United States
chemical_list: D000932:Antiemetics; D000970:Antineoplastic Agents; D004164:Diphosphonates; D017829:Granisetron; D017294:Ondansetron; D000077268:Pamidronate